Oncogenic Osteomalacia Associated with Phosphaturic Mesenchymal Tumor of the Thigh: A Case Report
International Journal of Development Research
Oncogenic Osteomalacia Associated with Phosphaturic Mesenchymal Tumor of the Thigh: A Case Report
Received 20th November, 2017; Received in revised form 23rd December, 2017; Accepted 13th January, 2018; Published online 28th February, 2018.
Copyright © 2018, Shravan Shetty et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Oncogenic Osteomalacia (OOM) is an uncommon metabolic and bone disease caused by Fibroblast Growth Factor 23 (FGF 23),a phosphaturic factor produced by phosphaturic mesenchymal tumors characterized by phosphate leakage from the kidneys and subsequent hypophosphatemia. We present the case of oncogenic osteomalacia in a 50 year old woman who presented to our hospital with complaint of being unable to walk since 5 years. She had been initially diagnosed with low phosphorus level and treated with oral phosphate powder for 3 years. After a complete diagnostic evaluation, she was diagnosed with a phosphaturic mesenchymal tumor of the thigh. The patient underwent surgery. Post surgery, the patient had complete recovery.
